Utah Retirement Systems’s Aurinia Pharmaceuticals AUPH Stock Holding History

Utah Retirement Systems’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Hold	25,272	–	–	﹤0.01%	825
2026 Q1	$375K	Hold	25,272	–	–	﹤0.01%	798
2025 Q4	$403K	Hold	25,272	–	–	﹤0.01%	801
2025 Q3	$279K	Hold	25,272	–	–	﹤0.01%	910
2025 Q2	$214K	Hold	25,272	–	–	﹤0.01%	958
2025 Q1	$203K	Hold	25,272	–	–	﹤0.01%	936
2024 Q4	$227K	Hold	25,272	–	–	﹤0.01%	938
2024 Q3	$185K	Hold	25,272	–	–	﹤0.01%	971
2024 Q2	$144K	Hold	25,272	–	–	﹤0.01%	954
2024 Q1	$127K	Hold	25,272	–	–	﹤0.01%	952
2023 Q4	$227K	Hold	25,272	–	–	﹤0.01%	936
2023 Q3	$196K	Hold	25,272	–	–	﹤0.01%	945
2023 Q2	$245K	Hold	25,272	–	–	﹤0.01%	930
2023 Q1	$277K	Hold	25,272	–	–	﹤0.01%	881
2022 Q4	$109K	Hold	25,272	–	–	﹤0.01%	945
2022 Q3	$190K	Hold	25,272	–	–	﹤0.01%	932
2022 Q2	$254K	Hold	25,272	–	–	﹤0.01%	914
2022 Q1	$313K	Hold	25,272	–	–	﹤0.01%	887
2021 Q4	$578K	Buy	+25,272	New	+$599K	0.01%	848

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Utah Retirement Systems's AUPH Position: Q2 2026 in Review

Utah Retirement Systems held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 25,272 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #825.

Utah Retirement Systems first reported a position in AUPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $578K in Q4 2021. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Utah Retirement Systems held 25,272 shares of Aurinia Pharmaceuticals worth $429K as of Q2 2026.
Utah Retirement Systems left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Utah Retirement Systems's portfolio in Q2 2026, its #825 holding.
Utah Retirement Systems first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
Utah Retirement Systems's Aurinia Pharmaceuticals position peaked at $578K in Q4 2021.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.